Related Experiment Videos
Inhibitors of genetic recombination in pneumococci
Abstract:
Treatment of transformable pneumococci with DNA-intercalating agents shortly after the uptake of DNA molecules inhibited the appearance of genetic transformants. The same drug treatments applied 20 min after DNA uptake were ineffective. Ethidium bromide, proflavin, daunomycin, actinomycin D, and platinum red were found to be effective inhibitors. Donor DNA molecules reisolated from the drug-treated bacteria appeared to be associated with the resident DNA in an abnormal manner, and they had only poor transforming activity.
Insights
DNA-intercalating agents, like ethidium bromide, prevent genetic transformation in pneumococci when applied immediately after DNA uptake. Delaying treatment renders these agents ineffective, suggesting a critical early window for intervention.
Area of Science:
- Microbiology
- Molecular Biology
- Genetics
Background:
- Bacterial transformation is a key mechanism for horizontal gene transfer.
- Understanding the early stages of DNA integration is crucial for controlling genetic exchange.
Purpose of the Study:
- To investigate the effect of DNA-intercalating agents on bacterial genetic transformation.
- To determine the optimal timing for inhibiting transformation using these agents.
Main Methods:
- Treatment of transformable *Streptococcus pneumoniae* with various DNA-intercalating agents (e.g., ethidium bromide, proflavin) at different time points post-DNA uptake.
- Analysis of genetic transformant appearance.
- Isolation and characterization of donor DNA molecules from treated bacteria.
Main Results:
- Immediate application of DNA-intercalating agents post-DNA uptake significantly inhibited genetic transformant formation.
- Treatment applied 20 minutes after DNA uptake showed no inhibitory effect.
- Isolated donor DNA from treated bacteria exhibited abnormal association with resident DNA and reduced transforming activity.
Conclusions:
- DNA-intercalating agents are effective inhibitors of pneumococcal transformation only when administered during a narrow early window after DNA acquisition.
- The mechanism of inhibition likely involves interference with the early stages of DNA integration or processing.